CompletedNot Applicable

Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery

South Korea44 participantsStarted 2021-05-10

Plain-language summary

For successful intraoperative neuromonitoring (IONM), adequate reversal of neuromuscular blocking agent is a prerequisite in thyroid surgery with . The aim of this study is to investigate the feasibility of neostigmine just after tracheal intubation on the IONM in thyroid surgery.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * open thyroid surgery with intraoperative neuromonitoring Exclusion Criteria: * refusal to participate in the study * rocuronium should not be used (e.g. renal dysfunction patient)

What they're measuring

Time to recovery of cricothyroid muscle twitching

Timeframe: perioperative

Trial details

NCT IDNCT04873531

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-08-23

View on ClinicalTrials.gov More Thyroid Diseases trials